𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New evidence for the cardiovascular benefits of long chain omega-3 fatty acids

✍ Scribed by Susan N. Hansen; William S. Harris

Publisher
Current Science Inc.
Year
2007
Tongue
English
Weight
170 KB
Volume
9
Category
Article
ISSN
1523-3804

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Biomarkers of long-chain PUFA omega-3 fa
Biomarkers of long-chain PUFA omega-3 fatty acids and the human nutritional status
✍ Bruno Berra; Gigliola Montorfano; Manuela Negroni; Paola Corsetto; Angela Maria πŸ“‚ Article πŸ“… 2009 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 739 KB

## Abstract The association of dietary fats with disease risk or outcome can be determined from epidemiological studies and/or from food frequency questionnaires; a better assessment of the dietary intake of the long‐chain polyunsaturated fatty acids omega‐3 is obtained by the fatty acid compositio

Issues surrounding fish as a source of o
Issues surrounding fish as a source of omega-3 long-chain polyunsaturated fatty acids
✍ Douglas Tocher πŸ“‚ Article πŸ“… 2009 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 381 KB

## Abstract Fish are a virtually unique, rich source of omega‐3 long‐chain polyunsaturated fatty acids (Ο‰3 LC‐PUFA) in the human diet. This article describes the origins of Ο‰3 LC‐PUFA in fish and the increasingly important role of aquaculture in the provision of fish for human consumption. It also

How good is the evidence for a favourabl
How good is the evidence for a favourable effect of very long chain n-3 polyunsaturated fatty acids on cardiovascular disease?
✍ John Stanley πŸ“‚ Article πŸ“… 2010 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 411 KB

## Abstract The evidence for beneficial effects of very long chain (VLC) n‐3 polyunsaturated fatty acids (PUFA) on cardiovascular disease (CVD) is strong because it is based on the results of adequately powered intervention trials with disease endpoints. This contrasts with the evidence for a detri